Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 884546 SAN FRANCISCO, CA
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$605,183
+$530,384 QoQ
Shares Held
61,943
+361.3% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 96 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. KPTI ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in KPTI

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $605,183 61,943
2026-03-31 $74,799 13,429
2024-12-31 $34,592 51,173
2024-09-30 $42,330 51,000
2024-06-30 $44,268 51,000
2024-03-31 $467,962 309,909
2023-12-31 $268,071 309,909
2023-09-30 $346,938 258,909
2023-06-30 $544,773 304,343
2023-03-31 $866,345 222,711
2022-12-31 $703,225 206,831
2022-09-30 $1,094,735 200,501
2022-06-30 $901,896 199,977
2022-03-31 $1,431,231 194,197
2021-12-31 $1,209,798 188,149
2021-09-30 $1,095,027 188,149
2021-06-30 $4,799,398 465,058
2021-03-31 $4,757,606 452,244
2020-12-31 $7,230,228 467,069
2020-09-30 $7,532,271 515,909
2020-06-30 $8,404,075 443,721
2020-03-31 $7,417,710 386,138